Norma Group AG NA O.N. (NOEJ)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 15.02 |
|---|---|
| 52-week range | 12.48 – 21.15 |
| Return, 1 month / 3 months | −9.8% / −18.2% |
| Return, 1 year / 3 years | +1.8% / −2.5% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 37.7% |
| Worst drawdown (1 year) | -28.8% |
| Average daily value traded | 1.88M EUR |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NORMA Group is a German manufacturer of engineered joining technology. The company makes clamps, connectors, quick-release couplings and fluid-handling systems used to join pipes, hoses and other components. Its customers come from the automotive industry, general industrial manufacturing and water management, where reliable connections matter. NORMA Group is based in Maintal, Germany, and supplies manufacturers and installers in many countries through its own operations and distribution partners.
Norma Group AG NA O.N. trades under the code NOEJ on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Norma Group AG NA O.N. (NOEJ) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 15.02 on 23 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 366 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.8% and over the last three months it fell 18.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -10.2% | ||
| From 52-week high | -27.6% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -18.2% | ||
| 6-month return | 3.7% | ||
| 12-month return, skipping the last month | 12.9% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 37.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.8% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 1.88M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 34 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.5% |
|---|---|
| 1 month | −9.8% |
| 3 months | −18.2% |
| 6 months | +3.7% |
| 1 year | +1.8% |
| 3 years | −2.5% |
| 5 years | −53.2% |
Signals
| 50-day / 200-day average | 17.81 / 16.72 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.71 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Jul 2026 | EUR 0.1400 |
| 14 May 2025 | EUR 0.4000 |
| 17 May 2024 | EUR 0.4500 |
| 12 May 2023 | EUR 0.5500 |
| 30 May 2022 | EUR 0.7500 |
| 18 May 2022 | EUR 0.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.